Cargando…
Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells
Autophagy is the process of lysosome-mediated degradation and recycling that functions as an adaptive survival mechanism during anti-cancer therapy. Aberrant activation of the phosphoinositide-3-kinase (PI3K) pathway frequently occurs in solid tumors, including cervical cancer. However, single-agent...
Autores principales: | Kim, Hyun-Jung, Lee Yoon, Soo, Young, Chan Kim, Hwan, Yun Kim, Ju, Woong, Cheol, Seung Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351656/ https://www.ncbi.nlm.nih.gov/pubmed/28036259 http://dx.doi.org/10.18632/oncotarget.14245 |
Ejemplares similares
-
Pik3ip1 Modulates Cardiac Hypertrophy by Inhibiting PI3K Pathway
por: Song, Hong Ki, et al.
Publicado: (2015) -
Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer
por: Wang, Dong, et al.
Publicado: (2016) -
Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway
por: Chen, Zhihang, et al.
Publicado: (2020) -
PIK3CA Mutations in Hepatocellular Carcinoma in Korea
por: Kim, Heesue, et al.
Publicado: (2013) -
PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
por: Payne, S N, et al.
Publicado: (2015)